IMVT- Immunovant, Inc.

Name: Immunovant, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunovant, Inc. (IMVT) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Venker Eric	1.48M	$42.69M	-
Other	Geffner Michael	218.0K	$6.31M	-
Other	Stout Jay S	199.7K	$5.78M	-
COO	Gloria Melanie	175.9K	$5.09M	-
Other	Van Tuyl Christopher	152.2K	$4.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 5, 2024	Salzmann Peter51	Chief Executive Officer	Sell	3,824	$38.59	$147,568.16	-0.4%	-27.9%	-42.0%
Dec 1, 2023	Migausky George V	Director	Sell	12,700	$39.73	$504,567.30	-3.6%	-12.8%	-30.5%
Dec 1, 2023	Pande Atul74	Director	Sell	12,350	$39.73	$490,667.50	-4.5%	-12.8%	-30.5%
Dec 1, 2023	Fromkin Andrew J.45	Director	Sell	12,350	$39.73	$490,696.72	-4.2%	-12.8%	-30.5%
Nov 22, 2023	Salzmann Peter51	Chief Executive Officer	Sell	16,217	$32.78	$531,581.07	-0.8%	+14.8%	-18.8%
Nov 22, 2023	Barnett Eva Renee58	Chief Financial Officer	Sell	4,055	$32.78	$132,919.83	-0.6%	+14.8%	-18.8%
Nov 22, 2023	Butchko Julia G.46	Chief Development Officer	Sell	3,265	$32.78	$107,024.23	-0.4%	+14.8%	-18.8%
Nov 22, 2023	MacIas William L.51	Chief Medical Officer	Sell	3,265	$32.78	$107,024.23	-0.5%	+14.8%	-18.8%
Nov 22, 2023	Levine Mark S.66	Chief Legal Officer	Sell	3,252	$32.78	$106,598.48	-0.5%	+14.8%	-18.8%
Oct 25, 2023	Levine Mark S.66	Chief Legal Officer	Sell	4,107	$34.66	$142,348.62	-1.3%	+15.9%	-10.2%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC